Glow Lifetech Corp. (GLOW.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.64 Million CAD | 26.63% |
| 2022 | -2.24 Million CAD | 80.18% |
| 2021 | -11.31 Million CAD | -7274.73% |
| 2020 | -153.47 Thousand CAD | -173.41% |
| 2019 | -56.13 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -261.82 Thousand CAD | 47.38% |
| 2024 Q2 | -258.78 Thousand CAD | 1.16% |
| 2023 Q1 | -379.6 Thousand CAD | 52.31% |
| 2023 FY | -1.64 Million CAD | 26.63% |
| 2023 Q4 | -497.54 Thousand CAD | -35.97% |
| 2023 Q3 | -365.91 Thousand CAD | 7.71% |
| 2023 Q2 | -396.47 Thousand CAD | -4.44% |
| 2022 Q2 | -516.73 Thousand CAD | 13.91% |
| 2022 FY | -2.24 Million CAD | 80.18% |
| 2022 Q1 | -600.22 Thousand CAD | -186.51% |
| 2022 Q4 | -795.97 Thousand CAD | -156.44% |
| 2022 Q3 | -310.39 Thousand CAD | 39.93% |
| 2021 Q4 | 693.81 Thousand CAD | 252.65% |
| 2021 FY | -11.31 Million CAD | -7274.73% |
| 2021 Q1 | -10.38 Million CAD | -104373.65% |
| 2021 Q2 | -1.17 Million CAD | 88.73% |
| 2021 Q3 | -454.5 Thousand CAD | 61.16% |
| 2020 FY | -153.47 Thousand CAD | -173.41% |
| 2020 Q4 | 9958.00 CAD | 111.68% |
| 2020 Q3 | -85.27 Thousand CAD | -119.42% |
| 2020 Q2 | -38.86 Thousand CAD | 1.13% |
| 2020 Q1 | -39.3 Thousand CAD | -70.88% |
| 2019 Q4 | -23 Thousand CAD | 34.99% |
| 2019 Q2 | 23.83 Thousand CAD | 210.41% |
| 2019 Q3 | -35.38 Thousand CAD | -248.46% |
| 2019 Q1 | -21.58 Thousand CAD | 0.0% |
| 2019 FY | -56.13 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 75.733% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 79.998% |
| BetterLife Pharma Inc. | -2.88 Million CAD | 43.039% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 78.593% |
| ChitogenX Inc. | -1.55 Million CAD | -5.895% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | 61.788% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 87.527% |
| Entheon Biomedical Corp. | -300 Thousand CAD | -448.536% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | 68.455% |
| Lexston Life Sciences Corp. | -867.71 Thousand CAD | -89.649% |
| Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | -111.026% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | -384.22% |
| MYND Life Sciences Inc. | -1.51 Million CAD | -8.417% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | -34.399% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | 47.177% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | -29.121% |
| Telescope Innovations Corp. | -5.72 Million CAD | 71.267% |